Skip to main content
Psoriatic Arthritis ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
Crosswords
Psoriatic Arthritis Workup
Publish date:
April 14, 2022
Recommended Reading
Reduced humoral response to SARS-CoV-2 vaccine in patients receiving systemic therapy for PsA
Psoriatic Arthritis ICYMI
Scoring by MRI is an effective way to identify change in clinical outcomes of PsA
Psoriatic Arthritis ICYMI
PsA: Deucravacitinib shows promise in phase 2
Psoriatic Arthritis ICYMI
Degree of disease control influences abnormalities in renal parameters in PsA
Psoriatic Arthritis ICYMI
Degree of disease control influences abnormalities in renal parameters in PsA
Psoriatic Arthritis ICYMI
Secukinumab shows a satisfactory retention rate in PsA in real-world setting
Psoriatic Arthritis ICYMI
Effect of burdensome symptoms on treatment preferences of patients with PsA
Psoriatic Arthritis ICYMI
Slight improvement in axial PsA with DMARD therapy irrespective of HLA-B27 status
Psoriatic Arthritis ICYMI
Clinical Edge Journal Scan Commentary: PsA April 2022
Psoriatic Arthritis ICYMI
Apremilast has neutral effect on vascular inflammation in psoriasis study
Psoriatic Arthritis ICYMI
Psoriatic Arthritis
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge